The Scientific Research Team at Aktis Oncology focuses on the discovery and development of innovative targeted radiopharmaceuticals to treat various solid tumor cancers. This multidisciplinary team conducts cutting-edge research encompassing chemistry, manufacturing, pharmacokinetics, and biology to advance the company's therapeutic pipeline.
Andrew Clay
Scientist
Anna Schaefer
Research Associate
Dasa Lipovsek
Vp, Lead Discovery
Erin D Swiger
Senior Scientist
Hanna Barry
Senior Research Associate
Howard Sauls
Principal Scientist
Mark Woodward
Senior Scientist, DMPK
Michael Doligalski
Principal Scientist, Head Of D...
Srividhya G Subraman...
Associate Scientist
Tyler Benedum
SVP & Head of Chemistry, Manuf...
View all